| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Related Subjects:Migraine |Basilar Migraine |Cluster Headaches |Sumatriptan |Tension Headache |Analgesic Overuse Headache |Headaches in General |CADASIL
🧠 Migraine is a chronic, episodic neurological disorder causing recurrent headaches with associated features such as nausea 🤢, vomiting, photophobia 😎, and phonophobia 🔊. It affects ~1 in 10 people, more common in women (14%) than men (4%). Onset is often in childhood or young adulthood.
| Score | Grade | Disability |
|---|---|---|
| 0 to 5 | MIDAS Grade I | Little or no disability |
| 6 to 10 | MIDAS Grade II | Mild disability |
| 11 to 20 | MIDAS Grade III | Moderate disability |
| 21+ | MIDAS Grade IV | Severe disability |
🧠 Core idea: treat early, use adequate doses, avoid opioids, and assess for medication-overuse headache if acute treatments are being used frequently.
| Treatment | Usual adult dose / use | Key cautions |
|---|---|---|
| 🛏️ Rest / environment | Dark, quiet room; sleep can abort an attack. | Useful supportive measure but should not delay analgesia if severe. |
| 💊 NSAID
Ibuprofen |
400 mg PO, up to 600 mg if appropriate. | Avoid/caution in peptic ulcer disease, CKD, anticoagulation, severe heart failure, uncontrolled hypertension, late pregnancy. |
| 💊 NSAID
Naproxen |
500 mg PO initially, then 250 mg if needed depending on local guidance. | Longer acting; useful if recurrence occurs. Same NSAID cautions. |
| 💊 Aspirin | 900 mg PO for acute migraine. | Avoid in children <16 years, aspirin allergy, active peptic ulcer disease, significant bleeding risk, and late pregnancy unless specialist-advised. |
| 💊 Paracetamol | 1 g PO | Useful if NSAIDs contraindicated; avoid overdose and caution in severe liver disease. |
| 💊 Triptan
Sumatriptan |
50–100 mg PO, or 20 mg intranasal, or 6 mg SC for severe/rapid-onset attacks or vomiting. | Avoid in ischaemic heart disease, previous stroke/TIA, peripheral vascular disease, uncontrolled hypertension. Avoid in hemiplegic, basilar/brainstem or retinal migraine unless specialist-advised. |
| 🤢 Antiemetic
Metoclopramide / prochlorperazine |
Use for nausea/vomiting and to improve gastric emptying/absorption. Can be used even if nausea is absent. | Metoclopramide: extrapyramidal side effects, dystonia, avoid prolonged use. Prochlorperazine: sedation, dystonia, hypotension. |
| 🧬 Rimegepant | Specialist / NICE option for acute treatment in selected adults when triptans are contraindicated, not tolerated or ineffective. | CGRP receptor antagonist. Check local formulary and drug interactions. |
| Drug / treatment | Typical use | Important adverse effects / cautions |
|---|---|---|
| 🫀 Propranolol | Common first-line preventive option. Start low and titrate, e.g. 40 mg twice daily, adjusted to response/tolerability. | Avoid/caution in asthma, COPD with bronchospasm, bradycardia, heart block, hypotension. May cause fatigue, vivid dreams, depression, erectile dysfunction. |
| 🫀 Atenolol | Alternative beta-blocker, often off-label for migraine prevention. | Same beta-blocker cautions; dose adjust in renal impairment. |
| 🌙 Amitriptyline | Useful if insomnia, depression, anxiety, neuropathic pain or tension-type headache overlap. Start low, e.g. 10 mg nocte, titrate slowly. | Sedation, dry mouth, constipation, urinary retention, QT risk, falls risk in older adults. |
| 💊 Topiramate | Effective preventive option; start low and titrate slowly. | Paraesthesia, cognitive slowing, weight loss, mood effects, renal stones, glaucoma risk. Teratogenic; subject to UK pregnancy-prevention restrictions and avoid in pregnancy unless strict criteria met. |
| 🧃 Candesartan | Effective off-label option, especially if hypertension coexists. | Dizziness, hypotension, hyperkalaemia, renal impairment. Avoid in pregnancy. |
| 🩸 Menstrual migraine short-term prevention
Frovatriptan |
2.5 mg twice daily, usually from 2 days before expected menstruation for 5–6 days. | Useful for predictable menstrual migraine. Apply usual triptan cardiovascular cautions. |
| 💉 Botulinum toxin type A | Specialist option for chronic migraine: headache on ≥15 days/month, with migraine features on ≥8 days/month, after failure of several preventives. | Neck pain, injection-site pain, weakness, ptosis. Not used for episodic migraine. |
| 🧬 CGRP monoclonal antibodies
erenumab, fremanezumab, galcanezumab, eptinezumab |
Specialist options for frequent episodic or chronic migraine after failure of multiple preventives, depending on NICE/local criteria. | Injection/infusion reactions, constipation especially erenumab, hypersensitivity. Long-term safety and pregnancy data limited. |
| 🧬 Gepants for prevention
rimegepant / atogepant |
NICE-supported specialist options for selected adults after failure of multiple preventives. Atogepant can be used for episodic or chronic migraine prevention under NICE criteria. | Nausea, constipation, fatigue; check hepatic impairment and drug interactions. |
Migraine is a neurovascular disorder characterised by recurrent disabling headaches, often with aura. Key subtypes: - Without aura (commonest, unilateral throbbing, N/V, photophobia). - With aura (transient neurological symptoms, often visual). - Hemiplegic migraine (motor aura, mimics stroke). - Status migrainosus (prolonged, severe, emergency). - Chronic migraine (≥15 headache days/month, often with medication overuse). Management is stepwise: trigger avoidance → acute therapy (NSAIDs, triptans, antiemetics) → preventive therapy if frequent/severe (beta-blockers, topiramate, valproate, CGRP mAbs). Always consider red flags (first or worst headache, neuro deficits, papilloedema).